Some younger women who have an increased risk of osteoporosis might
also benefit from bone tests, according to guidelines released today
from the U.S. Preventive Services Task Force. This might include
smokers, women who drink excessively, and women who are underweight
or have a parent who has fractured a hip.
"Since many people don't know they have osteoporosis until they have
a fracture, screening gives us a chance to prevent these fractures
from happening," said task force member Dr. Chien-Wen Tseng of the
University of Hawaii John A. Burns School of Medicine in Honolulu.
In women, reduced estrogen production during menopause and afterward
can slow production of new bone tissues. Over time, this process
increases their risk of osteoporosis.
There still isn't enough evidence to say exactly which younger women
need bone tests or to say for sure whether men would also benefit
from osteoporosis screenings, the Task Force notes in guidelines
published in JAMA that are in line with previous recommendations
from 2011.
"Most studies on screening and treatment have focused on women since
the highest risk factors are being female, older, and having gone
through menopause," Tseng said by email. "Thus, the Task Force found
good evidence that screening and treatment of osteoporosis prevents
fractures in women."
"In men, we know we can screen accurately for osteoporosis," Tseng
said. "However, there are fewer studies in men . . . so we do not
know if treating men for osteoporosis would prevent fractures."
Also, it's unclear if drugs that work in women might also be
effective in men, Tseng noted.
By 2020, approximately 12 million adults 50 and older in the U.S.
alone are expected to have osteoporosis, the Task Force notes.
Fractures caused by osteoporosis can cause chronic pain and
disability.
Because changes in bone mineral density happen slowly in most women,
doctors don't always agree on the ideal time to do bone tests or how
often to repeat them.
Women go through menopause when they stop menstruating, typically
between ages 45 and 55 but sometimes earlier or later.
[to top of second column] |
"We don't have conclusive evidence showing when postmenopausal women
should start screening, or whether a list of risk factors works
better than age alone to identify women under age 65 who should have
a bone density test," said Dr. Margaret Gourlay of the University of
North Carolina at Chapel Hill, author of an accompanying editorial.
"I hope the Task Force can do a formal analysis of those issues
later," Gourlay said by email. "If age works as well as a long list
of risk factors, doctors should order bone density tests for
postmenopausal women based on age alone, similar to how screening
tests for cancer are ordered."
When tests do show osteoporosis, women are most often treated with
medicines known as bisphosphonates, which work by slowing down how
fast the body removes old bone, allowing time to regrow bone and
make fractures less likely. This family of drugs includes Fosamax (alendronate
sodium), Actonel (risedronate sodium) and Boniva (ibandronate
sodium).
These medicines can cause nausea and abdominal pain, as well as rare
but more serious side effects like cracks in the thighbone or damage
to the jawbone. Alternative treatments include estrogen or two
injected medicines, denosumab and teriparatide.
Even though the Task Force stopped short of recommending tests for
men, there's already evidence that bone tests can accurately
identify men who have a high risk of fractures, said Jane Cauley of
the University of Pittsburgh, author of a separate editorial.
Male smokers, for example, have a higher risk of osteoporosis than
other men, and some previous research suggests they might benefit
from screening and treatment approaches similar to those applied to
older women.
"Low bone mineral density predicts fractures in men," Cauley said by
email. "The relationship is even stronger in men compared to women."
SOURCE: http://bit.ly/2KoetVH JAMA, online June 26, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |